Concentrix (NASDAQ:CNXC) Releases Q1 2026 Earnings Guidance

Concentrix (NASDAQ:CNXCGet Free Report) updated its first quarter 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 2.570-2.690 for the period. The company issued revenue guidance of $2.5 billion-$2.5 billion. Concentrix also updated its FY 2026 guidance to 11.480-12.070 EPS.

Concentrix Stock Down 8.1%

Concentrix stock opened at $40.48 on Tuesday. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 1.10. The stock has a 50 day moving average of $38.43 and a two-hundred day moving average of $46.77. Concentrix has a twelve month low of $31.63 and a twelve month high of $66.00. The stock has a market capitalization of $2.52 billion, a price-to-earnings ratio of 8.56, a PEG ratio of 0.59 and a beta of 0.48.

Concentrix (NASDAQ:CNXCGet Free Report) last issued its quarterly earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.93 by $0.02. The business had revenue of $2.55 billion for the quarter, compared to analyst estimates of $2.54 billion. Concentrix had a net margin of 3.25% and a return on equity of 16.02%. The business’s revenue was up 4.3% compared to the same quarter last year. During the same period in the previous year, the business posted $3.26 earnings per share. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. As a group, research analysts expect that Concentrix will post 10.11 earnings per share for the current year.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the stock. Wall Street Zen raised shares of Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, October 25th. Robert W. Baird lowered their price objective on shares of Concentrix from $75.00 to $62.00 and set an “outperform” rating for the company in a research note on Monday, September 29th. Weiss Ratings upgraded shares of Concentrix from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday. Canaccord Genuity Group reiterated a “buy” rating and set a $80.00 target price on shares of Concentrix in a report on Tuesday, September 23rd. Finally, Barrington Research restated an “outperform” rating and set a $62.00 target price on shares of Concentrix in a research note on Monday. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $66.25.

View Our Latest Stock Report on Concentrix

Insider Buying and Selling

In other Concentrix news, CEO Christopher A. Caldwell purchased 1,000 shares of the business’s stock in a transaction on Friday, October 31st. The stock was bought at an average cost of $40.00 per share, with a total value of $40,000.00. Following the acquisition, the chief executive officer owned 287,661 shares of the company’s stock, valued at $11,506,440. The trade was a 0.35% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 3.20% of the company’s stock.

Key Stories Impacting Concentrix

Here are the key news stories impacting Concentrix this week:

  • Positive Sentiment: Barrington Research reaffirmed an “outperform” rating and set a $62.00 price target, signaling analyst conviction that shares have upside from current levels. Read More.
  • Neutral Sentiment: Concentrix reported fiscal Q4 and full-year 2025 results; the release is driving today’s market action as investors parse revenue, margins and management commentary for forward guidance. Read More.
  • Neutral Sentiment: Pre-earnings previews and valuation looks have been published, giving investors context on expectations and multiples ahead of the print; these pieces discuss whether recent share moves and valuation are warranted. Read More.
  • Neutral Sentiment: Coverage pieces and earnings previews outline key items to watch (revenue growth, margin trends, contract mix and guidance), which can amplify volatility as the market digests results. Read More.
  • Neutral Sentiment: Reported short-interest data in the feed is anomalous (shows zero shares), so it does not appear to be a meaningful driver of today’s move based on the available figures.
  • Negative Sentiment: Analysts and articles flag concern that while Concentrix has previously beaten guidance, expected revenue growth is slowing — investors often punish stocks when earnings beats are accompanied by weaker growth outlooks. Read More.
  • Negative Sentiment: Commentary questioning whether current pricing reflects Concentrix’s multi?year share decline and changing fundamentals may reinforce selling pressure until there’s clearer guidance or an earnings rebound. Read More.

Hedge Funds Weigh In On Concentrix

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Larson Financial Group LLC increased its holdings in shares of Concentrix by 224.9% during the 3rd quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock valued at $32,000 after acquiring an additional 479 shares during the last quarter. Geneos Wealth Management Inc. boosted its position in Concentrix by 532.7% during the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after purchasing an additional 522 shares during the period. Johnson Financial Group Inc. acquired a new position in Concentrix during the third quarter valued at approximately $69,000. Osaic Holdings Inc. raised its position in shares of Concentrix by 13.4% in the second quarter. Osaic Holdings Inc. now owns 2,222 shares of the company’s stock valued at $118,000 after purchasing an additional 263 shares during the period. Finally, Federated Hermes Inc. lifted its stake in shares of Concentrix by 81.6% in the second quarter. Federated Hermes Inc. now owns 4,294 shares of the company’s stock worth $227,000 after buying an additional 1,930 shares during the last quarter. Institutional investors and hedge funds own 90.34% of the company’s stock.

Concentrix Company Profile

(Get Free Report)

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology?driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back?office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.

Featured Articles

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.